Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
HeartView is a medical technology company specializing in artificial intelligence-driven solutions for cardiac imaging, with a primary focus on fetal echocardiography. The company's platform automates the interpretation of ultrasound images to improve the detection of congenital heart defects (CHDs) during prenatal screenings. By leveraging deep learning algorithms, HeartView aims to standardize cardiac assessments and reduce the high rate of missed diagnoses in fetal heart exams. Their technology assists clinicians in identifying complex anatomical structures and potential abnormalities more accurately and efficiently. The company's mission is to improve neonatal outcomes through earlier and more reliable diagnosis of heart conditions.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on HeartView.